AF Advisors’s AbbVie ABBV Stock Holding History

AF Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-960	Closed	-$219K	–	27
2025 Q4	$219K	Hold	960	–	–	0.08%	26
2025 Q3	$222K	Buy	+960	New	+$195K	0.09%	26
2025 Q2	–	Sell	-960	Closed	-$201K	–	29
2025 Q1	$201K	Buy	+960	New	+$187K	0.04%	22
2022 Q3	–	Sell	-1,380	Closed	-$211K	–	16
2022 Q2	$211K	Buy	+1,380	New	+$211K	0.13%	19
2022 Q1	–	Sell	-1,480	Closed	-$200K	–	14
2021 Q4	$200K	Buy	+1,480	New	+$175K	0.11%	25
2021 Q3	–	Sell	-1,800	Closed	-$203K	–	24
2021 Q2	$203K	Buy	+1,800	New	+$203K	0.1%	23

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AF Advisors's ABBV Position: Q1 2026 in Review

AF Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 960 shares — an estimated $219K sold.

AF Advisors first reported a position in ABBV in Q2 2021 and held it in 6 quarters. The position peaked at $222K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

AF Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
AF Advisors sold 960 AbbVie shares in Q1 2026, an estimated $219K.
AF Advisors first reported a position in AbbVie in Q2 2021 and held it in 6 quarters.
AF Advisors's AbbVie position peaked at $222K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AF Advisors's 13F filing for Q1 2026, filed 1 May 2026.